Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Bruker ( (BRKR) ) just unveiled an update.
On February 18, 2025, Bruker Corporation expanded its Board of Directors to ten members, appointing Laura Francis as an independent director and future member of the Audit Committee. Francis, the CEO of SI-BONE, Inc., brings extensive experience in the medtech and life science industries, which is expected to aid Bruker’s growth and strategy execution.
More about Bruker
Bruker Corporation is a leader in the post-genomic era, providing high-performance scientific instruments and analytical solutions for life sciences and diagnostics. The company focuses on enabling innovation and productivity in various research fields, including molecular and cell biology, biopharma applications, microscopy, nanoanalysis, and semiconductor metrology.
YTD Price Performance: -10.02%
Average Trading Volume: 1,516,288
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.02B
Learn more about BRKR stock on TipRanks’ Stock Analysis page.
